Abstract:Inflammation regulated by interleukin (IL) 8 promotes metastasis of hepatocellular carcinoma (HCC). The transcription factor forkhead box C1 (FOXC1) promotes metastasis by activating the epithelial to mesenchymal transition; its levels in liver tumors have been associated with shorter survival times of patients. We investigated whether FOXC1 activates inflammation signaling pathways in HCC cell lines.We performed studies in the human HCC cell lines Huh-7 and SMMC7721, as well as the metastatic cell lines MHCC97H and HCCLM3. Cell lines were incubated with IL8 and transcription of reporter genes was measured; cells were also incubated with kinase inhibitors. Levels of FOXC1 or IL8 were knocked down with small interfering messenger RNAs in Huh7 cells; cells were analyzed in vitro in migration and invasion assays. To study metastasis, HCC cells were injected into flanks of BALB/C nude mice; 4 weeks later, the subcutaneous tumor fragments were collected and implanted into livers of the nude mice, and number and size tumors formed were measured. Chromatin immunoprecipitation assays were used to measure binding of transcription factors promoter regions of genes. We measured levels of FOXC1, IL8, CXCR1, and CCL2 in 2 groups of human HCC tissues collected from the Xijing or Tongji Hospitals in China (n = 690 and n = 312 samples, respectively) using immunohistochemistry.Incubation of HCC cells with IL8 led to increased expression of FOXC1, via activation of phosphoinositide 3-kinase signaling to AKT and hypoxia-inducible factor 1α. Knockdown of FOXC1 in HCC cells that overexpressed IL8 reduced the numbers of metastases formed in mice, compared with cells without FOXC1 knockdown. Transgenic overexpression of FOXC1 in HCC cells with IL8 knockdown increased the numbers of metastases formed in mice compared with cells without FOXC1 overexpression. CXCR1 and CCL2 were direct transcriptional targets of FOXC1. Knockdown of the combination of CXCR1 and CCL2 reduced the invasive activities of HCC cells that overexpress FOXC1 and formation of lung metastases in mice, and transgenic overexpression of CXCR1 increased cell's invasive and metastatic abilities after knockdown of FOXC1. Liver metastases grown from cells that overexpressed FOXC1 were infiltrated by tumor-associated macrophages, and CCL2 knockdown decreased tumor-associated macrophage infiltration; depletion of macrophages from mice significantly reduced growth of metastases by cells that overexpressed FOXC1. In human HCC tissues, level of FOXC1 correlated with levels of IL8 and CXCR1 and CCL2 and infiltration of tumors by macrophage. In multivariate analysis, detection of FOXC1 and CCL2 were independent predictors for postoperative recurrence of HCC and overall survival.In HCC cell lines, IL8 activates expression of FOXC1 via the phosphoinositide 3-kinase signaling to AKT and hypoxia-inducible factor 1α. FOXC1 expression leads to transactivation of CXCR1 and CCL2, promoting inflammation and the invasive and metastatic abilities of HCC cells.

IRE1α‑XBP1 Signaling Pathway Regulates IL‑6 Expression and Promotes Progression of Hepatocellular Carcinoma

Targeting the IRE1α-XBP1s Axis Confers Selective Vulnerability in Hepatocellular Carcinoma with Activated Wnt Signaling

Distinct Role of Interleukin-6 and Tumor Necrosis Factor Receptor-1 in Oval Cell- Mediated Liver Regeneration and Inflammation-Associated Hepatocarcinogenesis

IL-6 Upregulates the Expression of IL-6R Through the JAK2/STAT3 Signalling Pathway to Promote Progression of Hepatocellular Carcinoma

IRE1α-XBP1 Pathway Promotes Melanoma Progression by Regulating IL-6/STAT3 Signaling

Dual role for inositol-requiring enzyme 1α in promoting the development of hepatocellular carcinoma during diet-induced obesity in mice.

Excessive Activation of HOXB13/PIMREG Axis Promotes Hepatocellular Carcinoma Progression and Drug Resistance

Inhibitory effects of transcription factor Ikaros on the expression of liver cancer stem cell marker CD133 in hepatocellular carcinoma.

IL-6 Promotes Hepatocellular Carcinoma Invasion by Releasing Exosomal miR-133a-3p

XBP1s acts as a transcription factor of IRE1α and promotes proliferation of colon cancer cells

Aberrant Upregulation of Indoleamine 2,3-Dioxygenase 1 Promotes Proliferation and Metastasis of Hepatocellular Carcinoma Cells via Coordinated Activation of AhR and β-Catenin Signaling

Activation of IRE1α-XBP1 Pathway Induces Cell Proliferation and Invasion in Colorectal Carcinoma.

IL-6/STAT3 Is a Promising Therapeutic Target for Hepatocellular Carcinoma

Interleukin-6 Enhances Cancer Stemness and Promotes Metastasis of Hepatocellular Carcinoma Via Up-Regulating Osteopontin Expression.

Hypoxia‐inducible Factor‐1α/interleukin‐1β Signaling Enhances Hepatoma Epithelial–mesenchymal Transition Through Macrophages in a Hypoxic‐inflammatory Microenvironment

APOBEC3B and IL-6 Form a Positive Feedback Loop in Hepatocellular Carcinoma Cells

Inflammation-Dependent IL18 Signaling Restricts Hepatocellular Carcinoma Growth by Enhancing the Accumulation and Activity of Tumor-Infiltrating Lymphocytes

Increased Expression of Iaspp, Regulated by Hepatitis B Virus X Protein-Mediated NF-κB Activation, in Hepatocellular Carcinoma

Interleukin-8 Induces Expression of FOXC1 to Promote Transactivation of CXCR1 and CCL2 in Hepatocellular Carcinoma Cell Lines and Formation of Metastases in Mice

Expression and Critical Role of Interleukin Enhancer Binding Factor 2 in Hepatocellular Carcinoma

INTERLEUKIN 1-MEDIATED HOXC10 OVEREXPRESSION PROMOTES HEPATOCELLULAR CARCINOMA METASTASIS BY UPREGULATING PDPK1 AND VASP